| Ytd | -38.11% | |
| 1y | -90.35% |
| Open | 0.16 | Prev Close | 0.17 | Low | 0.16 | High | 0.17 | Mkt Cap | 2.64M |
| Vol | 513.97K | Avg Vol | 11.59M | EPS | -0.95 | P/E | N/A | Forward P/E | -0.78 |
| Beta | N/A | Short Ratio | 1.34 | Inst. Own | 1.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.21 | 200-d Avg | 0.33 | 1yr Est | 3.50 |
AZTR News
Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-m
Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market sessi
Gainers Tenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-mar
SAGTEC GLOBAL (NASDAQ: SAGT) gained 75.6% in pre-market trading after projecting 35% revenue growth
Azitra shares jumped 25.45% after-hours following volatile trading session, financing updates and up
New Initiatives:ATR-COSF: Expansion into Cosmetic IngredientsOne of the most exciting initiatives en
Anitra (AMEX:AZTR) reported quarterly losses of $(0.25) per share which missed the analyst consensus
Azitra shares are trading higher Friday after announcing $10.5 million in private placement, with po
Dow falls 100+ points, S&P 500 and NASDAQ also down. Energy sector sees gains, consumer discreti
Planet Labs (PL) stock rose in pre-market trading after better-than-expected Q4 sales and strong FY2
Azitra shares jumped over 44% in after-hours trading following a $31.4 million financing deal to adv
Initial funding of approximately $10.5MM in convertible preferred stock and up to an additional $20.
Azitra, Inc. (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovativ
https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_02042026_AZTR_Vandermosten.pdf
Anitra (AMEX:AZTR) reported quarterly losses of $(0.81) per share which missed the analyst consensus
U.S. stock futures rose on Friday following Thursday's declines. Futures of major benchmark indi
